Gotowe bibliografie tematyczne / Alzheimer's disease

Spis treści

  1. Artykuły w czasopismach
  2. Rozprawy doktorskie
  3. Książki
  4. Części książek
  5. Streszczenia konferencji
  6. Raporty organizacyjne

Gotowa bibliografia na temat „Alzheimer's disease”

Autor: Grafiati
Data publikacji: 4 czerwca 2021
Data aktualizacji: 25 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Alzheimer's disease”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Alzheimer's disease"

1

Zarrouk, Amira, Meryam Debbabi, Maryem Bezine, et al. "Lipid Biomarkers in Alzheimer's Disease." Current Alzheimer Research 15, no. 4 (2018): 303–12. http://dx.doi.org/10.2174/1567205014666170505101426.

Pełny tekst źródła
Streszczenie:
Background: There are now significant evidences that lipid metabolism is affected in numerous neurodegenerative diseases including Alzheimer’s disease. These dysfunctions lead to abnormal levels of certain lipids in the brain, cerebrospinal fluid and plasma. It is consequently of interest to establish lipid profiles in neurodegenerative diseases. This approach, which can contribute to identify lipid biomarkers of Alzheimers' disease, can also permit to identify new therapeutic targets. It was therefore of interest to focus on central and peripheral biomarkers in Alzheimer's disease. Methods: A
Style APA, Harvard, Vancouver, ISO itp.
2

Graham, Nori. "Alzheimer's Disease International." International Psychogeriatrics 9, no. 1 (1997): 5–6. http://dx.doi.org/10.1017/s1041610297004146.

Pełny tekst źródła
Streszczenie:
Alzheimer's Disease International (ADI) aims to promote and support the work of national Alzheimer associations. Their main purpose is to support carers of people with Alzheimer's disease and related dementias, and to raise awareness of the impact of the disease on the individual and the carer.
Style APA, Harvard, Vancouver, ISO itp.
3

Rajesh, Ravula, Singadi Akhil Reddy, Gandikota Varma Devraj, Raghuram Bhukya, Harika Dasari, and Naaram Srichandana. "Region-based Convolutional Neural Network Driven Alzheimer’s Severity Prediction." International Journal on Recent and Innovation Trends in Computing and Communication 11, no. 6 (2023): 465–70. http://dx.doi.org/10.17762/ijritcc.v11i6.7784.

Pełny tekst źródła
Streszczenie:
It's important to note that Alzheimer's disease can also affect individuals over the age of 60, and in fact, the risk of developing Alzheimer's increases with age. Additionally, while deep learning approaches have shown promising results in detecting Alzheimer's disease, they are not the only techniques available for diagnosis and treatment. That being said, using Region-based Convolutional Neural Network (RCNN) for efficient feature extraction and classification can be a valuable tool in detecting Alzheimer's disease. This new approach to identifying Alzheimer's disease could lead to a more a
Style APA, Harvard, Vancouver, ISO itp.
4

VanDongen, Antonius M. "Arc: A new target for treating alzheimer's disease." Open Access Government 43, no. 1 (2024): 160–61. http://dx.doi.org/10.56367/oag-043-11454.

Pełny tekst źródła
Streszczenie:
Arc: A new target for treating alzheimer's disease Antonius M. VanDongen, Associate Professor from Duke University, walks us through Arc, a new target for treating Alzheimer’s disease. Alois Alzheimer is a German psychiatrist credited with identifying the first case of the debilitating disease named after him. In 1906, he described neurofibrillary tangles and amyloid plaques in his patient’s brain as unique hallmarks of her dementia. Advances in neuroimaging, genetics, and molecular biology have expanded our understanding of the mechanisms underlying Alzheimer’s disease (AD) significantly. But
Style APA, Harvard, Vancouver, ISO itp.
5

Rimmer, Elizabeth. "Alzheimer's Disease International." International Psychiatry 3, no. 4 (2006): 22–23. http://dx.doi.org/10.1192/s1749367600004999.

Pełny tekst źródła
Streszczenie:
Alzheimer's Disease International (ADI) is the international federation of 75 Alzheimer associations throughout the world and is in official relations with the World Health Organization. ADI was established to raise awareness about dementia, strengthen Alzheimer associations and provide a platform for the exchange of knowledge with the ultimate goal of improving the quality of life of people with dementia and their families.
Style APA, Harvard, Vancouver, ISO itp.
6

BAR, Hassan. "Various Infections and Alzheimer's Disease." Virology & Immunology Journal 7, no. 3 (2023): 1–3. http://dx.doi.org/10.23880/vij-16000317.

Pełny tekst źródła
Streszczenie:
Alzheimer's disease (AD) is a major contributor to the worldwide prevalence of dementia. Extracellular-amyloid (A) senile plaques (SP) and intracellular neurofibrillary tangles (NFT) are the neuropathological hallmarks of Alzheimer's disease. Currently, it is believed that both hereditary and environmental variables interact to contribute to the pathophysiology of AD. Despite significant investments in neurological research, the precise molecular basis of AD pathogenesis remains unknown. Multiple studies point to the possibility that pathogenic microorganisms contribute to the development of A
Style APA, Harvard, Vancouver, ISO itp.
7

Zhao, Bin. "Statistical analysis on Alzheimer's disease." Journal of Infectious Diseases & Travel Medicine 7, no. 2 (2023): 1–18. http://dx.doi.org/10.23880/jidtm-16000177.

Pełny tekst źródła
Streszczenie:
Alzheimer's disease is a progressive neurodegenerative disease that occurs mostly in the elderly and has memory impairment as the main clinical symptom. There is no ideal treatment for Alzheimer's disease, so early prevention is important. In this paper, we use brain structural information to diagnose Alzheimer's disease features and cognitive-behavioral characteristics, which is important for early and accurate diagnosis of mild cognitive impairment. To investigate the factors influencing Alzheimer's disease, a correlation analysis model was developed after preprocessing the missing values of
Style APA, Harvard, Vancouver, ISO itp.
8

Conte, G. L., and M. Pomponi. "Alzheimer's or alzheimer-perusini's disease?" European Psychiatry 22 (March 2007): S297. http://dx.doi.org/10.1016/j.eurpsy.2007.01.1008.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Corriveau, Roderick A., Walter J. Koroshetz, Jordan T. Gladman, et al. "Alzheimer's Disease–Related Dementias Summit 2016: National research priorities." Neurology 89, no. 23 (2017): 2381–91. http://dx.doi.org/10.1212/wnl.0000000000004717.

Pełny tekst źródła
Streszczenie:
Goal 1 of the National Plan to Address Alzheimer’s Disease is to prevent and effectively treat Alzheimer disease and Alzheimer disease–related dementias by 2025. To help inform the research agenda toward achieving this goal, the NIH hosts periodic summits that set and refine relevant research priorities for the subsequent 5 to 10 years. This proceedings article summarizes the 2016 Alzheimer's Disease–Related Dementias Summit, including discussion of scientific progress, challenges, and opportunities in major areas of dementia research, including mixed-etiology dementias, Lewy body dementia, fr
Style APA, Harvard, Vancouver, ISO itp.
10

Ojetunde, Ayodeji Oluwatobi. "The Neuroprotective and Therapeutic Effects of Medicinal Plants and Natural Products against Aluminium Chloride-Induced Alzheimer’s Disease: Recent Update." Biology, Medicine, & Natural Product Chemistry 13, no. 1 (2024): 7–33. http://dx.doi.org/10.14421/biomedich.2024.131.7-33.

Pełny tekst źródła
Streszczenie:
Alzheimer's disease currently affects more than 35 million individuals worldwide. Aluminium has been implicated in the pathogenesis of various cognitive disorders. Meanwhile, aluminium chloride (AlCl3) has a significant impact on the progression of neurodegenerative diseases including Alzheimer's disease. The majority of Alzheimer's disease medications now on the market are cholinesterase inhibitors. However, the effectiveness of these drugs is limited because they can't totally arrest the progression of the disease. The utilization of medicinal plants and natural products may present excellen
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Rozprawy doktorskie na temat "Alzheimer's disease"

1

Russell, Teresa. "Alzheimer's disease : expressed concern for problem behaviors /." free to MU campus, to others for purchase, 1997. http://wwwlib.umi.com/cr/mo/fullcit?p1390668.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Navaratnam, Dasakumar Selveraj. "Cholinesterases in Alzheimer's disease." Thesis, University of Oxford, 1990. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.306734.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Newman, Tracey Anne. "Ageing and Alzheimer's disease." Thesis, University of Southampton, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.246220.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Montacute, Rebecca. "Infection in Alzheimer's disease." Thesis, University of Manchester, 2017. https://www.research.manchester.ac.uk/portal/en/theses/infection-in-alzheimers-disease(a69fbf77-1455-4a78-a700-54815cad926d).html.

Pełny tekst źródła
Streszczenie:
Infections are a common co-morbidity in Alzheimer's disease (AD), and evidence suggests that infections can exacerbate neuroinflammation and increase cognitive decline in AD patients. In AD, immune changes are observed both in the central nervous system (CNS) and in the rest of the body. However, only a few studies have investigated immune responses to infection in AD. Here, two extensively studied infections, Toxoplasma gondii (T. gondii) and Trichuris muris (T. muris) were used to investigate infection in AD. T. gondii is a protozoan parasite which is common globally, including in the develo
Style APA, Harvard, Vancouver, ISO itp.
5

Zubair, Mohammed. "Metabolomics in Alzheimer's disease." Thesis, University of Manchester, 2013. https://www.research.manchester.ac.uk/portal/en/theses/metabolomics-in-alzheimers-disease(0872757b-d25a-4c43-bd52-915d4cad21c6).html.

Pełny tekst źródła
Streszczenie:
Metabolites are a potentially useful source of detecting and identifying disease specific biomarkers. This thesis investigates the possibility of using metabolomics applications to detect Alzheimer’s disease associated metabolite peaks in patients and to detect longitudinal changes of the disease. Serum samples and clinical data were collected from 60 healthy controls and 60 Alzheimer’s disease patients (60 at baseline and 60 at 12 month follow-up). The metabolic fingerprinting of serum samples using the FT-IR lacked discriminatory power to discriminate Alzheimer’s disease and non-disease samp
Style APA, Harvard, Vancouver, ISO itp.
6

Shie, Feng-Shiun. "Cholesterol and Alzheimer's disease /." Thesis, Connect to this title online; UW restricted, 2000. http://hdl.handle.net/1773/6604.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

梁欣珮 and Yan-pui Irene Leung. "Potential impact of alzheimer's disease on retina." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2009. http://hub.hku.hk/bib/B42905059.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Hynd, Matthew. "Excitotoxic neurodegeneration in Alzheimer's disease /." [St. Lucia, Qld.], 2004. http://www.library.uq.edu.au/pdfserve.php?image=thesisabs/absthe18145.pdf.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Blom, Elin. "Genetic Studies of Alzheimer's Disease." Doctoral thesis, Uppsala universitet, Institutionen för folkhälso- och vårdvetenskap, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-9397.

Pełny tekst źródła
Streszczenie:
Patients with Alzheimer's disease (AD) often have a family history of the disease, implicating genetics as a major risk factor. Three genes are currently known to cause familial early-onset AD (<65 years): the amyloid precursor protein (APP) and the presenilins (PSEN1 and PSEN2). For the much more common late-onset disease (>65 years), only the APOE gene has repeatedly been associated to AD, where the ε4 allele increases disease risk and decreases age at onset. As APOE ε4 only explains part of the total estimated disease risk, more genes are expected to contribute to AD. This thesis has
Style APA, Harvard, Vancouver, ISO itp.
10

Bakerink, Ronda Ann. "Semantic memory in Alzheimer's Disease." Thesis, University of British Columbia, 1988. http://hdl.handle.net/2429/27795.

Pełny tekst źródła
Streszczenie:
Alzheimer's Disease is characterized by a general decline in cognitive functioning. Although phonology are relatively unaffected, patients with Alzheimer's Disease have been reported to have deficits of semantic memory. Thirteen patients with dementia, five of whom had a confirmed diagnosis of dementia, participated in the study. The purpose of this investigation was to replicate a study performed by Mark Byrd (1984), using Alzheimer's Disease patients. Subjects were presented with category-word decision pairs, for which the task was to decide if the word was an exemplar of the category, and c
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Książki na temat "Alzheimer's disease"

1

1936-, Wurtman Richard J., ed. Alzheimer's disease. Raven Press, 1990.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Dempsey, Denise P. Alzheimer's disease. Science Reference Section, Science and Technology Division, Library of Congress, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Dempsey, Denise P. Alzheimer's disease. Science Reference Section, Science and Technology Division, Library of Congress, 1997.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

D, Terry Robert, Katzman Robert, and Bick Katherine L, eds. Alzheimer disease. Raven Press, 1993.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

D, Terry Robert, Katzman Robert, and Bick Katherine L, eds. Alzheimer disease. Raven Press, 1994.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Molloy, William. Alzheimer's disease. Firefly Books, 2003.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Molloy, William. Alzheimer's disease. Key Porter Books, 1998.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Hooper, Nigel M. Alzheimer's Disease. Humana Press, 1999. http://dx.doi.org/10.1385/1592591957.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Richter, Ralph W., and Brigitte Zoeller Richter. Alzheimer's Disease. Humana Press, 2003. http://dx.doi.org/10.1385/1592596614.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Strock, Margaret. Alzheimer's disease. National Institutes of Health, National Institute of Mental Health, 1994.

Znajdź pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Więcej źródeł

Części książek na temat "Alzheimer's disease"

1

Hort, J., J. T. O'Brien, G. Gainotti, et al. "Alzheimer's Disease." In European Handbook of Neurological Management. Wiley-Blackwell, 2010. http://dx.doi.org/10.1002/9781444328394.ch16.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Khan, Qurat ul Ain, and Neill R. Graff-Radford. "Alzheimer's Disease." In Neurodegeneration. John Wiley & Sons, Ltd, 2017. http://dx.doi.org/10.1002/9781118661895.ch11.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Mandell, Alan M., and Robert C. Green. "Alzheimer's Disease." In The Handbook of Alzheimer's Disease and Other Dementias. Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9781444344110.ch1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Böning, Dieter, Michael I. Lindinger, Damian M. Bailey, et al. "Alzheimer's Disease." In Encyclopedia of Exercise Medicine in Health and Disease. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-540-29807-6_2076.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Galvin, James E. "Alzheimer's Disease." In Pathy's Principles and Practice of Geriatric Medicine. John Wiley & Sons, Ltd, 2012. http://dx.doi.org/10.1002/9781119952930.ch73.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Jamall, Selene, Sharanya Thiagarajan, and Dean Sherzai. "Alzheimer's Disease." In Lifestyle Medicine, Fourth Edition, 4th ed. CRC Press, 2024. http://dx.doi.org/10.1201/9781003227793-100.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Reddy, K. Jayasankara. "Alzheimer's Disease." In Essentials of Neuropsychology. Routledge, 2023. http://dx.doi.org/10.4324/9781032640839-17.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Saling, Michael M., Charles B. Malpas, and Rachel F. Buckley. "Alzheimer's Disease." In The SAGE Handbook of Clinical Neuropsychology. SAGE Publications Ltd, 2023. http://dx.doi.org/10.4135/9781529789522.n26.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Akhtar, Md Sayeed, Moteb Khobrani, Faheem Hyder Pottoo, and Jawad ur Rahman. "Alzheimer's Disease." In Neurochemical Systems and Signaling. CRC Press, 2023. http://dx.doi.org/10.1201/9780429265198-7.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Chaudhary, Raushan Kumar, Uday Venkat Mateti, Pukar Khanal, et al. "Alzheimer's Disease." In Computational and Experimental Studies in Alzheimer's Disease. CRC Press, 2024. http://dx.doi.org/10.1201/9781003412069-1.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Alzheimer's disease"

1

Pattanayak, Binod Kumar, Padmini Mansingh, Bibudhendu Pati, Bibhuti Bhusan Dash, Mahendra Kumar Gourisaria, and Sudhansu Shekhar Patra. "Alzheimer's Disease Classification using Capsule Network." In 2024 International Conference on Expert Clouds and Applications (ICOECA). IEEE, 2024. http://dx.doi.org/10.1109/icoeca62351.2024.00117.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

M, Prajna, Saumya Y. M, Shravya Shetty, Jaishma Kumari B, Pruthvi M. R, and Vaishnavi A. "Alzheimer's Disease Prediction Using Deep Learning." In 2024 IEEE International Conference on Distributed Computing, VLSI, Electrical Circuits and Robotics (DISCOVER). IEEE, 2024. http://dx.doi.org/10.1109/discover62353.2024.10750739.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Saini, Rajat, and K. P. Sharma. "Alzheimer's Disease Detection and Classification: A Survey." In 2024 First International Conference on Pioneering Developments in Computer Science & Digital Technologies (IC2SDT). IEEE, 2024. http://dx.doi.org/10.1109/ic2sdt62152.2024.10695982.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Nayaki, A. Periya, Arrchit Ramana M S, Prithivi Raj S. D, et al. "Alzheimer's Disease Detection using Machine Learning Models." In 2024 Third International Conference on Electrical, Electronics, Information and Communication Technologies (ICEEICT). IEEE, 2024. http://dx.doi.org/10.1109/iceeict61591.2024.10718398.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Pasternak, Logan, Srijohn Roy, Andrew Farag, Monica Rubens, Ameek Chadha, and Sasan Haghani. "IoT Mobile Application for Alzheimer's Disease Caregivers." In 2025 IEEE International Conference on Consumer Electronics (ICCE). IEEE, 2025. https://doi.org/10.1109/icce63647.2025.10929805.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
6

Hegde, Dhanya, Akshata Pandit, Trupthi Rao, and Ashwini Kodipalli. "Fuzzy Inference Model for Alzheimer's Disease Detection." In 2025 International Conference on Cognitive Computing in Engineering, Communications, Sciences and Biomedical Health Informatics (IC3ECSBHI). IEEE, 2025. https://doi.org/10.1109/ic3ecsbhi63591.2025.10991035.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Xu, Hao. "Exploring the effect of phototherapy of Alzheimer disease by advanced optical imaging in Alzheimer's disease mice model." In Optics in Health Care and Biomedical Optics XIV, edited by Qingming Luo, Xingde Li, Ying Gu, and Dan Zhu. SPIE, 2024. http://dx.doi.org/10.1117/12.3037355.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Rumao, Priti, and Mamta Padole. "Alzheimer's Disease." In DSMLAI '21': International Conference on Data Science, Machine Learning and Artificial Intelligence. ACM, 2021. http://dx.doi.org/10.1145/3484824.3484886.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Costa, Pedro Araujo. "Construction of an educational manual for caregivers of elderly people with Alzheimer's disease." In IV Seven International Congress of Health. Seven Congress, 2024. http://dx.doi.org/10.56238/homeivsevenhealth-010.

Pełny tekst źródła
Streszczenie:
Population aging has been occurring progressively and in Brazil there is an accelerating growth curve. According to the World Health Organization, dementia is one of the greatest public health challenges of the current generation, in which the Alzheimer's disease subtype accounts for the majority of diagnosed cases. In this context, this study aimed to describe the construction of an educational manual to support family caregivers of elderly people diagnosed with Alzheimer's disease. This is a descriptive, methodological study. Initially, a bibliographic survey was carried out on the subject i
Style APA, Harvard, Vancouver, ISO itp.
10

Collar, Giovanna Carello, Marco Antônio De Bastiani, and Eduardo R. Zimmer. "HUNTINGTON’S DISEASE AND EARLYONSET ALZHEIMER’S DISEASE SHARE A TRANSCRIPTOMIC SIGNATURE." In XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda082.

Pełny tekst źródła
Streszczenie:
Background: Neurodegenerative diseases share progressive loss of neurons and protein misfolding, which ultimately culminates in dementia; many diseases have been identified as causes of early-onset dementia (< 65 years of age) such as Huntington’s disease (HD) and early-onset Alzheimer’s disease (EOAD). Importantly, disease-specific genetic mutations have already been identified for HD and EOAD. Thus, one could suggest that the molecular link between these diseases may arise from alterations at the transcriptomic level, which is yet to be determined. Objective: We aimed at identifying trans
Style APA, Harvard, Vancouver, ISO itp.

Raporty organizacyjne na temat "Alzheimer's disease"

1

Huedepohl, Cole. Alzheimer's Disease & Gene Therapy. Iowa State University, 2023. http://dx.doi.org/10.31274/cc-20240624-149.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
2

Stevens, Brianna. Retinal Changes Associated with Alzheimer's Disease. Iowa State University, 2020. http://dx.doi.org/10.31274/cc-20240624-1231.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
3

Mehegan, Laura. Alzheimer's Disease and Dementia Awareness Poll 2018. AARP Research, 2018. http://dx.doi.org/10.26419/res.00232.001.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
4

Chandra, Amitabh, Courtney Coile, and Corina Mommaerts. What Can Economics Say About Alzheimer's Disease? National Bureau of Economic Research, 2020. http://dx.doi.org/10.3386/w27760.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
5

Han, Nana, Yang Fang, Guozhen Zhao, and Bo Ji. The comparative efficacy and safety of acupuncture for mild and moderate Alzheimer's disease: A systematic review and network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.11.0014.

Pełny tekst źródła
Streszczenie:
Review question / Objective: According to the current randomized clinical trials (RCT) of acupuncture therapy for Alzheimer's disease (AD), to evaluate their methodology, the quality of evidence and the report are evaluated and summarize evidence of important outcomes of randomized clinical trials. We aim to provide accurate clinical decision-making for acupuncture treatment of Alzheimer's disease. Condition being studied: According to the current randomized clinical trials (RCT) of acupuncture therapy for Alzheimer's disease (AD), to evaluate their methodology, the quality of evidence and the
Style APA, Harvard, Vancouver, ISO itp.
6

Mintzer, Jacobo E., D. L. Bachman, M. Stuckey, et al. A State-Wide Research Network for Alzheimer's Disease. Office of Scientific and Technical Information (OSTI), 2014. http://dx.doi.org/10.2172/1123171.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
7

Mehegan, Laura. Alzheimer's Disease and Dementia Awareness Poll 2018: Infographic. AARP Research, 2018. http://dx.doi.org/10.26419/res.00232.002.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
8

Pericak-Vance, Margaret A. Whole Exome Analysis of Early Onset Alzheimer's Disease. Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada602412.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
9

Pericak-Vance, Margaret A. Whole Exome Analysis of Early Onset Alzheimer's Disease. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada603027.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
10

Duncan, Marie. Alzheimer's Disease Caregivers: The Transition from Home Care to Formal Care. Portland State University Library, 2000. http://dx.doi.org/10.15760/etd.3220.

Pełny tekst źródła
Style APA, Harvard, Vancouver, ISO itp.
Możesz być także zainteresowany rozszerzonymi bibliografiami na temat „Alzheimer's disease” dla poszczególnych typów źródeł:
Artykuły w czasopismach Rozprawy doktorskie Książki
Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!

Do bibliografii